We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.31B
AUM Growth
+$234M
Cap. Flow
+$153M
Cap. Flow %
4.61%
Top 10 Hldgs %
29.6%
Holding
2,810
New
136
Increased
1,119
Reduced
861
Closed
104

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$16.7M
2
JPST icon
JPMorgan Ultra-Short Income ETF
JPST
+$12.1M
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$10M
4
IWB icon
iShares Russell 1000 ETF
IWB
+$9.45M
5
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$5.09M

Top Sells

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$3.19M
2
HD icon
Home Depot
HD
+$2.88M
3
COOP
Mr. Cooper
COOP
+$2.26M
4
PG icon
Procter & Gamble
PG
+$2.02M
5
CRM icon
Salesforce
CRM
+$1.9M

Sector Composition

Rank Sector Weight
1 Technology 22.8%
2 Financials 12.6%
3 Consumer Discretionary 7.91%
4 Healthcare 7.45%
5 Industrials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNXC icon
2126
Concentrix
CNXC
$1.5B
$13.3K ﹤0.01%
321
-611
-66% -$24.8K
MTW icon
2127
Manitowoc
MTW
$523M
$13.3K ﹤0.01%
1,110
+195
+21% +$2.22K
VSAT icon
2128
Viasat
VSAT
$10.2B
$13.3K ﹤0.01%
385
+165
+75% +$5.83K
CLB icon
2129
Core Laboratories
CLB
$518M
$13.3K ﹤0.01%
827
+120
+17% +$1.79K
AVAL icon
2130
Grupo Aval
AVAL
$5.72B
$13.3K ﹤0.01%
3,272
– –
SLVM icon
2131
Sylvamo
SLVM
$1.5B
$13.1K ﹤0.01%
272
-65
-19% -$2.96K
CSTL icon
2132
Castle Biosciences
CSTL
$741M
$13.1K ﹤0.01%
336
– –
ADMA icon
2133
ADMA Biologics
ADMA
$1.97B
$13K ﹤0.01%
713
-259
-27% -$4.37K
GEF icon
2134
Greif
GEF
$4.56B
$13K ﹤0.01%
192
+177
+1,180% +$11.1K
VHT icon
2135
Vanguard Health Care ETF
VHT
$18.3B
$13K ﹤0.01%
+45
New +$12.6K
AMRC icon
2136
Ameresco
AMRC
$1.12B
$12.9K ﹤0.01%
441
– –
RXRX icon
2137
Recursion Pharmaceuticals
RXRX
$1.6B
$12.9K ﹤0.01%
+3,153
New +$15.6K
RPC
2138
Ridgepost Capital
RPC
$957M
$12.8K ﹤0.01%
1,306
+986
+308% +$10K
FRSH icon
2139
Freshworks
FRSH
$2.99B
$12.8K ﹤0.01%
+1,043
New +$12.3K
RKLB icon
2140
Rocket Lab Corp
RKLB
$41.8B
$12.8K ﹤0.01%
183
+79
+76% +$4.53K
IBEX icon
2141
IBEX
IBEX
$467M
$12.8K ﹤0.01%
334
-6
-2% -$222
UPST icon
2142
Upstart Holdings
UPST
$2.63B
$12.7K ﹤0.01%
291
+137
+89% +$6.31K
AMBA icon
2143
Ambarella
AMBA
$2.99B
$12.6K ﹤0.01%
178
– –
LIND icon
2144
Lindblad Expeditions
LIND
$1.84B
$12.6K ﹤0.01%
872
-116
-12% -$1.46K
BFAM icon
2145
Bright Horizons
BFAM
$4.1B
$12.6K ﹤0.01%
124
– –
PRCT icon
2146
Procept Biorobotics
PRCT
$1.01B
$12.5K ﹤0.01%
398
+384
+2,743% +$12.7K
DNLI icon
2147
Denali Therapeutics
DNLI
$3.74B
$12.5K ﹤0.01%
758
-24
-3% -$405
SNCY
2148
DELISTED
Sun Country Airlines
SNCY
$12.5K ﹤0.01%
869
+136
+19% +$1.74K
TNDM icon
2149
Tandem Diabetes Care
TNDM
$1.18B
$12.5K ﹤0.01%
568
-564
-50% -$10.2K
ATMU icon
2150
Atmus Filtration Technologies
ATMU
$4.43B
$12.5K ﹤0.01%
240
– –
84 85
86
87 88

Similar funds

BDLIB
Banque de Luxembourg Investments (BLI) Luxembourg City, Luxembourg $3.34B AUM 11.13% 1-Year Est. Return
CS
CapitalatWork SA Auderghem $3.35B AUM
ECA
Encompass Capital Advisors New York $3.34B AUM 167.64% 1-Year Est. Return
TAM
Troy Asset Management London, United Kingdom $3.35B AUM 11.7% 1-Year Est. Return
5NCM
59 North Capital Management Houston, Texas $3.35B AUM 22.14% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
HP
Hancock Prospecting West Perth, Australia $3.33B AUM 65.96% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM

Quadrant Capital Group's Q4 2025 Portfolio in Review

As of Q4 2025, Quadrant Capital Group held 2,810 positions worth $3.31B, up 7.6% from $3.08B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $153M of net new capital in Q4 2025, opening 136 new positions and adding to 1,119 existing holdings. Its largest new stake was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dr. Reddy's Laboratories, an estimated $3.19M trimmed.

  • Quadrant Capital Group's largest Q4 2025 buy was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.
  • Quadrant Capital Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $16.7M increase.
  • Quadrant Capital Group's biggest Q4 2025 reduction was Dr. Reddy's Laboratories, cutting an estimated $3.19M.
  • Quadrant Capital Group fully exited Mr. Cooper in Q4 2025, selling an estimated $2.26M.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $3.31B portfolio in Q4 2025.
  • Quadrant Capital Group opened 136 new positions and closed 104 in Q4 2025.
  • Quadrant Capital Group's portfolio value rose 7.6% quarter-over-quarter to $3.31B.

Based on Quadrant Capital Group's 13F filing for Q4 2025, filed 13 Feb 2026.